Dan Harki @danharki.bsky.social · 03/06/2025When @doc-jlmeier.bsky.social tells me to buy merch, I buy. 040
Dan Harki @danharki.bsky.social · 12/05/2025Congratulations to Mackenzie and Laura! www.pharmacy.umn.edu/news/mackenz...pharmacy.umn.eduMackenzie Wyllie and Laura Hirsch Awarded Doctoral Dissertation FellowshipsThis prestigious award is bestowed upon the University's most outstanding PhD candidates for their accomplishments in highly significant and innovative research areas. 050
Reposted by Dan HarkiRSC Medicinal Chemistry @rscmedchem.rsc.org · 07/05/2025Take a look at recent work from Jared J. Anderson and @danharki.bsky.social on the identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)🔥⬇ pubs.rsc.org/en/content/a... 📍 @umnmedchem.bsky.social #chemsky🧪pubs.rsc.orgIdentification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)NF-κB inducing kinase (NIK) is the central regulatory component of noncanonical NF-κB signalling and has been implicated in a variety of cancers and immune disorders. While NIK has been pursued as a… 022
Dan Harki @danharki.bsky.social · 27/04/2025The #HarkiLab at the #MIKIW2025 meeting at the University of Kansas. 050
Dan Harki @danharki.bsky.social · 19/04/2025New work to characterize the ligandability of NIK with an electrophilic fragment. pubs.rsc.org/en/content/a...pubs.rsc.orgIdentification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK)NF-κB inducing kinase (NIK) is the central regulatory component of noncanonical NF-κB signalling and has been implicated in a variety of cancers and immune disorders. While NIK has been pursued as a t... 130
Reposted by Dan HarkiC&EN (Chemical & Engineering News) @cenmag.bsky.social · 27/03/2025Treating a deadly childhood cancer with a sideways approach: Degrading a critical scaffolding protein may help treat neuroblastoma. cen.acs.org/acs-news/acs... #chemsky🧪 #bioskycen.acs.orgTreating a deadly childhood cancer with a sideways approachDegrading a critical scaffolding protein may help treat neuroblastoma 1143